PTGS2 and colorectal carcinoma: EGLP enhanced CRC cell apoptosis by upregulating Bax, p-ERK and cleaved caspase-3 and downregulating Bcl-2, phosphorylated Akt1 (p-Akt1) and cyclooxygenase-2 (COX-2).